TP53 and leiomyoma: Accordingly, we were able to demonstrate that in leiomyoma cells in vitro treatment with nutlin-3, a small-molecule inhibitor of MDM2, activates the expression of canonical groups of genes associated with senescence and apoptosis downstream of p53 [9].